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Living with HIV and ARVs: Three-letter lives 
Section I  
Living with HIV and ARVs in the treatment possibility era 
1: Why the three letters matter 
This book is about living with the Human Immunodeficiency Virus, or HIV, and with 
antiretroviral, or ARV, therapy, the combination of medications that helps HIV positive 
people to live long and healthy lives.  Today, when ARV treatment is more and more 
available to those who need it, and is in prospect for those who do not yet have access, the 
two three-letter acronyms, HIV and ARV together, increasingly index people’s experiences 
of the pandemic. The book examines lives lived with HIV and ARVs in different national 
contexts, primarily the United Kingdom and South Africa, where I have conducted interviews 
about HIV support with people living with HIV, since 1993 in the United Kingdom (most 
recently in 2011), and since 2001 in South Africa (most recently in 2012).   
There have been dramatic improvements in people’s access to treatment, and in their 
health and life expectancies, across the pandemic. In the United Kingdom, ARVs arrived in 
1996. In South Africa, they began to be available in the early 2000’s, though rollout has been 
fastest since 2009.  The World Health Organisation has made strong moves to encourage 
earlier treatment, to preserve HIV positive people’s health so that illness does not 
compromise it before they start ARVs. South Africa is likely to join the United Kingdom in 
following these guidelines (World Health Organisation 2013). Annual HIV counselling and 
testing (HTC) became a universal expectation in South Africa in 2010, and it is an 
increasingly general part of primary health practice in the UK.  Both countries are working to 
reduce HIV stigma and discrimination, with some success (UNAIDS 2012a). These hopeful 
characteristics of the two epidemics are reflected more broadly in suggestions within 
international HIV policy that the end of the HIV pandemic may be in sight, and in 
assumptions within some social research that, whatever the practical problems, the pandemic 
no longer poses important theoretical issues.  
The major impetus for the book came from hearing my HIV positive research 
participants in both the United Kingdom and South Africa talk about the continuing 
difficulties of living three-letter lives. The interviews indicated that in many ways, despite 
positive indicators, the pandemic was very far from its end.  HIV’s naturalisation, that is, its 
incorporation into the natural order of people’s lives, through processes of medicalisation, 
  
social normalisation and marketisation, seemed to be stalling, undoing itself, and leaving 
things out (Squire 2010).  The interviews intimated that these difficulties derived partly from 
the global recession’s impact on three-letter lives, and the problems of living with HIV 
alongside many other illnesses, and with socio-economic constraints.  Other common 
difficulties were narrated around what it was like to be diagnosed, still a problematic moment 
although no longer a death sentence; telling and not telling people about being HIV positive, 
and their good and sometimes bad reactions; and the impact of HIV on children and 
relationships.  
Some of the commonalities across the interviews were less obviously about problems, 
more about the complex shape of HIV experiences.  This complexity was emblematised in 
the clouds of other acronyms suffusing the interview.  ‘HIV’ itself, for instance, was a term 
sometimes used interchangeably with ‘AIDS’ (as happened frequently, earlier in the 
epidemic).  ‘ARVs’ were described variously, across different national and socio-historical 
circumstances, as ‘ART’ (anti-retroviral therapy) or ‘HAART’ (Highly Active Anti-
Retroviral Therapy), or ‘combination therapy’. I have used the term ‘ARVs’ throughout this 
book because it was deployed by the majority of interviewees across both South African and 
UK studies. Another three-letter (or more accurately, two-letters-and-a-number) acronym, the 
CD4+ T cell count, signalling immune activity, was used by interviewees to indicate levels of 
health before and while taking treatment, together with ‘viral load’ numbers. The many three-
figure acronyms that hide behind or substitute for ARV brand or generic names, such as AZT 
(generic name,  Zidovudine), D4T (generic name, Stavudine) and 3TC (generic name, 
Lamivudine) , were regular currency within the interviews.  Three-letter lives now also 
encompass newer, still-uncertain uses and outcomes of ARVs, similarly acronymised. TasP 
(treatment as Prevention), PrEP (pre-exposure prophylaxis) and PEP (post-exposure 
prophylaxis) emblematise the acronymic optimism about treating away the pandemic 
expressed by many medical and policy organisations, though these acronyms, especially the 
first two,  were used less often by interviewees themselves.  The acronyms ‘MTCT’ or 
‘PMTCT’, for mother to child transmission, or prevention of mother to child transmission,  
indicate programmes to prevent vertical transmission that involve giving ARVs to both 
mother and baby, and that interviewees, women interviewees particularly, often mentioned. 
As with ‘HIV’ and ‘ARV,’ other acronymic descriptions of the epidemic have 
changed over time. The acronym PWA, ‘person with AIDS,’ developed, as Adam Mars-
Jones’ (1992) character in a story written early in the UK epidemic, ‘Slim,’ puts it, to remind 
  
people that he was indeed a person, has been modified, as treatment has developed and 
people live with HIV rather than progressing to AIDS, to ‘PLWHA’ or ‘person living with 
HIV/AIDS’. The call for VCT (voluntary counselling and testing) is now often superceded by 
emphasis on universal testing. The prevention mantra ‘ABC’, ‘Abstain, Be faithful, 
Condomise’, has given way to emphasis on condoms, circumcision, and work to reduce risky 
sexual encounters, and ARV-based prevention, especially TasP.  Treatment and prevention 
initiatives are now frequently related to another acronym, Millenium Development  Goal 6, 
or MDG 6, which aims to provide universal treatment access and to reverse the spread of 
HIV by 2015 (United Nations 2013). UNAIDS’s ‘three zeroes’, the triad of zero deaths from 
AIDS, zero new HIV infections and zero HIV-related discrimination, have shaped many 
prevention and treatment campaigns since 2010 (UNAIDS 2010b). HIV citizenship, which 
takes in the ways that people living with HIV or affected by HIV define themselves, and act 
and campaign in their social worlds, is related to an acronym, this time of four letters: GIPA, 
the principle of Greater Involvement of People Living with HIV and AIDS in all decisions 
made about them, which has been integral to international HIV policy since 1994 (UNAIDS 
2007). Within specific national contexts, local acronyms play large roles in HIV citizenship, 
particularly those of service and activist organisations such as THT (Terrence Higgins Trust) 
in the UK, and the TAC (Treatment Action Campaign) in South Africa.   
People do not live among all of these letters, all of the time.  Moreover, many 
problematic elementss of HIV experience are not acronymised. People who are HIV positive 
or otherwise affected by HIV and ARVs, however, do now tend to live with crowds of other 
acronyms as well.  They navigate their way through these swirls of letters extremely 
effectively, and the letters themselves can be useful. They signify medical social science and 
policy knowledge in condensed, appropriated and owned form, without people having to be 
HIV clinicians, epidemiologists, virologists, behavioural scientists or policy experts in order 
to use them.   
At the same time, acronyms can set up barriers for people who do not know what they 
mean. They can also create a sense of uncertainty among those who are HIV positive or HIV-
affected themselves, even if they use them, because of doubts about what, exactly, they mean, 
what precisely is the expertise they impart, and what their own relationship is to that 
expertise. The perpetual recoinings of HIV acronyms testify to the struggles for the power of 
definition and knowledge conducted by people living with the condition, as well as by 
doctors, policymakers and activists.   
  
It is medical, social and political shifts in addressing the pandemic that have made 
these particular sets of letters into powerful determinants of living with HIV. In 2008, the 
journalist Jonny Steinberg published a book about the difficulties South Africans were facing 
in getting tested for HIV and in accessing treatment. These difficulties arose not just from 
resource shortages, but also from competing belief systems, politically as well as culturally 
produced; concerns around social stigma and discrimination; and psychic conflicts, 
themselves the results of political and social as well as personal histories (Steinberg 2008). 
The book drew on interviews and encounters Steinberg had had in times and places where 
HIV was highly prevalent, mostly untreated, little talked about and usually fatal. In this book, 
called Three Letter Plague (Sizwe’s Test in the United States), ‘HIV’ were the three letters 
referred to.  In Living with HIV and ARVs, the arrays of letters framing the epidemic are 
multiple, ARVs are as important as HIV, treatment access is greatly improved, people have 
the potential for a long and healthy lifespan and stigma is reduced in high-prevalence 
situations (Zuch and Lurie 2012).  Difficulties, including some of those described by 
Steinberg, remain (Abrahams and Jewkes 2012; Flowers et al. 2006; Zungu 2012). 
Neverthess, Living with HIV and ARVs addresses the contemporary realities of the HIV 
pandemic as the difficulties of particular lives as citizens, rather than, as in Steinberg’s book, 
which appeared just five years ago, the problems of living in the midst of a plague. And 
Living with HIV and ARVs focuses on two sets of letters, not one, on ARVs as well as HIV, 
since these two three-letter sets, taken together, have increasing salience.  
One of the ways in which three letters can act is as a declaration. Just saying ‘HIV’, 
let alone saying ‘I am living with HIV’, makes an impact. But three letters can also be a kind 
of shorthand that evades the actualities of the condition, leaving behind its complexities and 
difficulties, especially when ‘ARVs’ are added to HIV, as if, by themselves, they constitute a 
solution.  On the other hand, ‘HIV’ itself may be too much to say. There are many codes for 
HIV to avoid saying it. One is indeed the ‘three-letter disease’. Others are expressions like 
‘this thing,’, ‘this torturing disease’, and in high-prevalence contexts, ‘our disease’.  The 
character in ‘Slim’ uses the eponymous term, first used to describe the illness in Africa, 
instead of ‘AIDS’, because it describes precisely what is happening to him, and plays 
ironically on the value attached to thinness in the West. This character also insists on his own 
terms for other aspects of HIV illness: ‘blackcurrants’, in place of Kaposi’s Sarcoma lesions, 
for instance (Mars-Jones 1992: 10).  His lexical creativity allows him to keep hold of his own 
bodily reality and at the same time to grasp broader control of a disease process that he 
  
cannot much affect, giving it his own meanings.  Oscar Moore, describing two years of his 
‘life as an acronym,’ also sketched out the ‘secret fraternity of sickness’ which build around 
the acronyms, conveying information, sympathy, rage and hope (1996: 3, 62).  These are 
some of the more empowering functions that the slew of words, abbreviations and rhetorical 
play around HIV, generates. 
Different forms of expression appear, of course, around other difficult health 
conditions like cancer (Sontag 1988), but they have been especially prolific within the HIV 
pandemic. We learn from them that indirectness can be helpful in allowing people to 
approach HIV issues obliquely (Squire 2007). However, indirectness can also be problematic. 
It can allow, through its imprecision, associations between HIV and areas of meaning such as 
sexuality, death and foreignness, that make it harder for people to understand HIV as an 
illness. In addition, with conditions like HIV, often characterised by privatised suffering and 
publicised silence, it can be very important for some people to talk openly and publicly, and 
for everyone to be able to talk openly in certain situations (Plummer 1995, 2001). Also, now 
that many people live with ARVs as well as HIV, the abjectification of HIV has diminished, 
so indirect ways of approaching it may be becoming less important (Abrahams and Jewkes 
2012; Zuch and Lurie 2012).  
At the same time, oblique strategies for approaching HIV continue, for a variety of 
reasons. People living with HIV and ARVs may have lived through a history of HIV as a 
‘death sentence’ that does not leave them. Even those who became HIV positive more 
recently have heard about and imagine that history, which is also the present reality for 
perhaps 16 million people needing and not receiving treatment (World Health Organisation 
2013; World Health Organisation/UNAIDS/UNICEF 2013).  Such a history is also close to 
the present for people whose treatment is physically or psychologically difficult, or medically 
failing. An AIDS-free generation may be in sight, but it is not a reality even for the half of 
HIV positive people now also living with ARVs. And so acronyms remain important both as 
indirect strategies for addressing the difficulties of the pandemic, and, paradoxically, as 
indices of optimism. 
The material in this book derives primarily from research participant interviews about 
experiences , expectations and requirements of HIV support in South Africa and the United 
Kingdom. In the early chapters especially, the book draws, too, on policy and cultural 
narratives of HIV, in the United Kingdom and South Africa, and at international levels. The 
  
book’s material also comes from listening to HIV volunteers and paid workers in South 
Africa and the United Kingdom, who, regardless of their status, are all citizens of an HIV-
affected, HIV-defined world to some degree, and who discussed many of the same issues as 
the research participants. In addition, much of the book draws on insights from students who 
have participated in my ‘HIV in the world’ module at the University of East London over the 
past five years, who themselves come from many different country contexts across the 
pandemic, particularly from sub-Saharan Africa and the Caribbean, and who raise many 
similar issues to the research participants.  
Often, students on the HIV module will say that the current policy picture cannot be 
right, and the figures must be wrong. They talk about all the people they know back home 
who don’t have free treatment available locally, who can’t get to treatment, who can’t afford 
the fees the clinics charge, who fear someone will see them in the clinic, who have never told 
anyone their test result or received any medical help after their diagnosis, or who, even now, 
have never gotten tested but have just accepted their illness and likely death.  In all this, they 
are frequently more pessimistic than workers in the HIV field, who are implementing change 
and measuring improvements, or indeed than my research participants, who, despite their 
extensive knowledge and understanding of the difficulties of three-letter lives, are well 
connected to treatment and education services. My students know, or sometimes are 
themselves, such people. They also know, or in some instances are themselves, people who 
do not access HIV services, do not know about services, do not know and will not consider 
their own HIV status. The continuing and new forms of difficulty around living with HIV and 
ARVs thus show themselves here too, in the conversations of people with close but often 
incidental connections to the pandemic. 
The many directions from which the difficulties, as well as the hopefulness, of 
contemporary three-letter lives appeared, defined the shape of this book. The book starts from 
a general consideration of a possible end of HIV ‘exceptionalism’ and the beginning of a new 
‘particularity’ about the pandemic. It continues by examining the different characteristics of 
HIV’s contemporary naturalisation – its medicalisation, normalisation and marketisation - 
and how these characteristics at the same time denaturalise HIV. It then proceeds to explicate 
how HIV’s particularities appear via its naturalisation and denaturalisation within two 
contemporary epidemics, in the United Kingdom and South Africa. In doing so, the book 
tries to describe and understand the new forms of HIV citizenship that are being articulated 
and performed within the current context of three-letter lives. 
  
Chapter 2 in the book’s first section, ‘Living with HIV in the treatment possibility 
era’, is called ‘From HIV’s exceptionalism to HIV’s particularity’.  It examines contemporary 
lives lived with HIV and ARVs in the context of medical, social and political gains within the 
HIV pandemic which promise to turn it into an everyday, rather than an exceptional, 
condition. It poses the ‘acronym’ optimism associated with this move away from 
exceptionalism, against continuing medical, social and political difficulties around HIV, as 
well as difficulties in the arena of personal beliefs and feelings. All of these difficulties still 
have powerful effects on the pandemic, and contribute to what the chapter calls its 
particularity. Chapter 2 goes on to describe the narrative approach to living with HIV and 
ARVs which I take in studying HIV support in the UK and South Africa, which allows for 
the particularities of lives within the pandemic to be registered. The chapter also describes 
how such studies, focused on the social, historical and personal particularities of epidemic 
contexts, may can also allow for transfer or translation of understandings across contexts. 
Section 2, ‘Being naturalised, being left behind’, examines the ways in which HIV has 
become part of everyday life, and the extent to which it has not, drawing both on my research 
studies, from the perspectives of people living with and affected by HIV, and on policy 
statements, professional position papers, corporate representations, and the discourses of 
HIV-related NGOs.   
 
Chapter 3, ‘Being naturalised’, discusses ways in which the pandemic is becoming 
naturalised, made to seem an inherent, regular and inalienable part of the established order of 
power relations through processes of medicalisation, normalisation, and marketisation. It also 
examines how these processes undermine themselves internally and at the same time undo 
HIV’s naturalisation, leaving lives lived with HIV to some extent outside or on the borders of 
naturalisation.   
 
Chapter 4, ‘When the drugs do work: The medicalised HIV citizen’,  explores the 
power of HIV’s naturalisation through medicalisation, the benefits of that medicalisation, the 
constraints operating through medicalisation, which reduce and simplify ways of thinking 
about the pandemic, and the effects of some complex personal and cultural HIV narratives 
which try to redefine HIV citizenship in the biological field.   
 
  
Chapter 5, ‘A long-term condition: HIV’s normalisation’, focuses on the second 
major naturalisation process operating around the contemporary pandemic, which I call 
normalisation. Normalisation has many positive aspects to it, and yet its mainstreaming of 
HIV concerns can make the particularities of the condition hard to talk about or even to 
recognise.  
 
Chapter 6, ‘Investing in the pandemic: The marketised HIV citizen’, examines the 
third naturalisation process in the contemporary pandemic, that of marketisation. This process 
increasingly structures arguments around prevention and treatment, and appears within 
personal as much as policy and popular accounts of the pandemic. It has become particularly 
prevalent since the financial crisis of 2008.   
 
Medicalisation, normalisation and marketisation are processes of naturalisation that 
appear in many different contemporary fields. Chapter 7,  ‘Being left behind’, goes on to 
examine some other denaturalising discontinuities in how the contemporary HIV era is lived, 
which derive from HIV's specific biological, psychological, cultural and socio-political 
characteristics. These discontinuities leave many people living with and affected by HIV, at 
some distance from the relatively hopeful HIV present. The chapter argues that both 
naturalisation and its failures lead to HIV being  ‘left behind,' and that this is an important 
element of HIV experience which requires continued attention.  
Section 3 examines the particularities of HIV epidemics as they play out in different 
modalities of naturalisation in two national contexts, those of the United Kingdom and South 
Africa, drawing predominantly on interviews conducted largely in 2011 and 2012, 
respectively. Chapter 8, ‘Living on: Three-letter lives in the United Kingdom’, develops the 
analysis of narratives built up in the previous chapters, in relation to the particularities of the 
UK epidemic. To do so, it draws on the fifth round of my study of support used and wanted 
for living with HIV in the United Kingdom, in which 47 people, roughly half gay men, and 
half women and heterosexual men, took part in semi-structured interviews, mostly in 2011. 
The chapter discusses how narratives of medicalisation and de-medicalisation, narratives of 
normalisation and non-normalisation, and narratives of marketisation and of living outside 
markets, are enacted within the context of UK HIV citizenship.  It is especially interested in 
how these three common narratives within the interviews, and their accompanying 
countervailing narratives, are inflected by what is often called neoliberalism. It examines 
  
what the narratives can tell us about the adequacy of this term in relation to the multiple,  
‘paraliberal’ ways people are developing of living with HIV and ARVs. It also investigates 
how the notion of living on a variety of HIV ‘borders’ of health, social and economic life, 
knowledge and resources (Derrida 1979) might be adapted to describe people’s active 
engagements with uncertainty and other difficulties.  
Chapter 9, ‘Living with HIV: Three-letter lives in South Africa,’ examines how the 
particularities of the pandemic are lived out in a high-prevalence, medium-income country 
context. Here, ‘living with’ HIV increasingly seems to characterise research participant 
narratives as they trace the relations between different HIV statuses, and between HIV and 
other conditions, particularly in terms of resources needed, mobilised and developed. The 
chapter suggests that social resources of ‘living with’ HIV, or a kind of HIV conviviality, 
have come to have important effects, not just for people who are HIV positive or affected by 
HIV. At the same time, people living with HIV in under-resourced contexts face particular 
difficulties of being left behind in resource terms, as well as those difficulties of HIV 
knowledge and understanding which people living with HIV in higher-income countries also 
face. 
Chapter 10, the last chapter in Section 3, reviews the particularities of contemporary 
three-letter lives as they have appeared in this book, and points to varieties of action and 
activism that may currently be available in everyday contexts such as those lived in by the 
interviewees in the HIV support studies. The chapter also  suggests that the complexities and 
contradictions of living with HIV and ARVs, and their socially and historically particular 
forms, come into view in the long, involved, reflexive and often creative stories that people 
living with HIV co-construct in interview situations. They are persuasive accounts of the 
particularities of HIV, and of the processes by which its contemporary socio-political place is 
being negotiated. 
To begin the book, I return now to the debate about current HIV optimism, how far 
concerns with HIV can be mainstreamed, and how we might be able to avoid separating and 
reifying the pandemic in an exceptionalist way, while still addressing its exceptional, 
particular characteristics. 
 
